Information
-
Trademark
-
78271471
-
Serial Number
78271471
-
Registration Number
2869554
-
International Classifications
-
Filing Date
July 08, 2003
21 years ago
-
Registration Date
August 03, 2004
20 years ago
-
Transaction Date
April 14, 2015
9 years ago
-
Status Date
March 06, 2015
9 years ago
-
Published for Opposition Date
May 11, 2004
20 years ago
-
Location Date
September 10, 2009
15 years ago
-
First Use Anywhere Date
December 31, 2000
24 years ago
-
First Use In Commerce Date
December 31, 2000
24 years ago
-
Status Code
710
-
Current Location
POST REGISTRATION
Employee Name
BUSH, KAREN K
-
Attorney Docket Number
T40626 USA
Attorney Name
Gary A. Hecht
Law Office Assigned Location Code
L50
-
Owners
Mark Drawing Code
1000
Mark Identification
SVELTONYL
Case File Statements
- GS0011: Biochemical and chemical compounds derived from natural, vegetal, marine, animal, synthetic and biotechnological extracts, used as ingredients for manufacturing cosmetics, namely skin care products for the purpose of moisturizing, soothing, conditioning and protecting
Case File Event Statements
-
3/6/2015 - 9 years ago
13 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Type: CAEX
-
12/18/2013 - 11 years ago
12 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
-
9/10/2009 - 15 years ago
11 - REGISTERED - SEC. 8 (6-YR) ACCEPTED
Type: 8.OK
-
8/28/2009 - 15 years ago
10 - TEAS SECTION 8 RECEIVED
Type: ES8R
-
3/30/2006 - 18 years ago
9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
8/3/2004 - 20 years ago
8 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
5/11/2004 - 20 years ago
7 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
4/21/2004 - 20 years ago
6 - NOTICE OF PUBLICATION
Type: NPUB
-
2/8/2004 - 21 years ago
5 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
1/26/2004 - 21 years ago
4 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
1/21/2004 - 21 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
9/26/2003 - 21 years ago
2 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
8/21/2003 - 21 years ago
1 - EMAIL RECEIVED
Type: EMRV